This study analyzed the characteristics of a calcium-related prognostic genes (CRPGs) signature in lung adenocarcinoma (LUAD) for prognostic value and explored TNNC1 as a potential therapeutic target for erlotinib resistance. The gene discussed is TNNC1; the disease is lung adenocarcinoma.